|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Stock-based compensation expense | |||||
| Deferred income taxes | |||||
| Unrecognized tax benefits | |||||
| Non-cash impact of foreign currency transactions | |||||
| Net realized losses on marketable investment securities | |||||
| Loss on inventory | |||||
| Gain on sale of businesses and assets | |||||
| Impairment of goodwill and long-lived assets | |||||
| (Gain) loss on termination of lease | |||||
| Gain on acquisition | |||||
| Other non-cash adjustments | |||||
| Changes in assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Trade accounts receivable | |||||
| Inventory | |||||
| Prepaid taxes | |||||
| Other assets | |||||
| Tenant improvement allowance received | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Capital expenditures | |||||
| Capitalization of intangible assets | |||||
| Proceeds from the sale of business, net cash sold | |||||
| Acquisitions, net of cash acquired | |||||
| Proceeds from sale of business and assets | |||||
| Purchases of marketable investment securities | |||||
| Proceeds from maturities and sales of marketable investment securities | |||||
| Net cash (used in) provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from common stock issued under stock-based compensation plans | |||||
| Payment of contingent consideration recognized at acquisition | |||||
| Payment of tax withheld for common stock issued under stock-based compensation plans | |||||
| Proceeds from underwritten public offering, net of costs and discounts | |||||
| Proceeds from revolving credit facility | |||||
| Repayment of revolving credit facility | |||||
| Total repayment of revolving credit facility | |||||
| Proceeds from the issuance of secured long-term credit facility | |||||
| Fees associated with issuance of secured long-term credit facility and refinancing of revolving credit facility | |||||
| Secured Debt | |||||
| Revolving Credit Facility | |||||
| Total fees associated with issuance of secured long-term credit facility and refinancing of revolving credit facility | |||||
| Release of cash held in escrow | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rates on cash, cash equivalents, and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of the period | |||||
| Cash, cash equivalents, and restricted cash at end of the period | |||||
Loading...